Axcella Health Inc (AXLA)

NASDAQ
1.710
-0.220(-11.40%)
After Hours
1.650
-0.060(-3.509%)
- Real-time Data
  • Volume:
    278,581
  • Day's Range:
    1.650 - 1.880
  • 52 wk Range:
    1.350 - 4.400

AXLA Overview

Prev. Close
1.93
Day's Range
1.65-1.88
Revenue
-
Open
1.73
52 wk Range
1.35-4.4
EPS
-1.73
Volume
278,581
Market Cap
90.02M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
140,929
P/E Ratio
-1.41
Beta
1.29
1-Year Change
-42.62%
Shares Outstanding
52,643,309
Next Earnings Date
Nov 16, 2022
What is your sentiment on Axcella Health?
or
Market is currently closed. Voting is open during market hours.

Axcella Health Inc News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Axcella Health Inc Analysis

Axcella Health Inc Company Profile

Axcella Health Inc Company Profile

Employees
59

Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. The company treats complex diseases and enhances health using endogenous metabolic modulator compositions. Its lead product candidates include AXA1665, which is in Phase 2 clinical trial for the reduction in risk of overt hepatic encephalopathy recurrence; and AXA1125 that is in Phase 2b clinical trial for treating non-alcoholic steatohepatitis, as well as in Phase 2a clinical trial for Long COVID therapy for patients. The company was formerly known as Newco LS16, Inc. and changed its name to Axcella Health Inc. in June 2016. Axcella Health Inc. was incorporated in 2008 and is based in Cambridge, Massachusetts.

Read More

Analyst Price Target

Average9.667 (+465.32% Upside)
High19
Low6
Price1.71
No. of Analysts6
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellStrong SellStrong SellStrong SellStrong Sell
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell